Literature DB >> 20501332

Up-regulated Golgi phosphoprotein 2 (GOLPH2) expression in lung adenocarcinoma tissue.

Fangfang Zhang1, Yanli Gu, Xiang Li, Wei Wang, Jianxing He, Tao Peng.   

Abstract

OBJECTIVES: The aim of the study was to evaluate Golgi Phosphoprotein 2 (GOLPH2) expression in lung cancer. DESIGN AND METHODS: GOLPH2 expression was analyzed from 178 lung cancer tumor tissue samples using immunohistochemistry. Levels of 133 lung cancer patients' serum GOLPH2 (sGOLPH2) were also quantitatively compared with 70 healthy individuals by a sandwich enzyme-linked immunosorbent assay (ELISA).
RESULTS: All adenocarcinoma (ADC) tissue samples (100%) displayed strong staining, 83.6% of which displayed cytoplasmic diffused staining. However, for squamous cell carcinoma samples, only 16.3% displayed strong staining intensity. Statistically, GOLPH2 expression in tissues of ADC was significantly higher than in other types of lung cancer (P<0.001). Levels of sGOLPH2 were also detected. The mean value of sGOLPH2 concentration is 69 ng/ml in lung cancer patients and 53 ng/ml in healthy individuals.
CONCLUSIONS: Significantly elevated GOLPH2 expression was observed in ADC tumor tissues. The levels of sGOLPH2 were about 30% higher in lung cancer patients compared with healthy individuals. 2010 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20501332     DOI: 10.1016/j.clinbiochem.2010.05.010

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  25 in total

1.  High expression of GP73 in primary hepatocellular carcinoma and its function in the assessment of transcatheter arterial chemoembolization.

Authors:  Ning Ai; Wei Liu; Zhi-Gang Li; Hong Ji; Bo Li; Guang Yang
Journal:  Oncol Lett       Date:  2017-08-01       Impact factor: 2.967

2.  Interleukin-6 and oncostatin M are elevated in liver disease in conjunction with candidate hepatocellular carcinoma biomarker GP73.

Authors:  Hongyan Liang; Timothy M Block; Mengjun Wang; Bradley Nefsky; Ronald Long; Julie Hafner; Anand S Mehta; Jorge Marrero; Robert Gish; Pamela A Norton
Journal:  Cancer Biomark       Date:  2012       Impact factor: 4.388

3.  The tumor-suppressive microRNA-143/145 cluster inhibits cell migration and invasion by targeting GOLM1 in prostate cancer.

Authors:  Satoko Kojima; Hideki Enokida; Hirofumi Yoshino; Toshihiko Itesako; Takeshi Chiyomaru; Takashi Kinoshita; Miki Fuse; Rika Nishikawa; Yusuke Goto; Yukio Naya; Masayuki Nakagawa; Naohiko Seki
Journal:  J Hum Genet       Date:  2013-11-28       Impact factor: 3.172

4.  Therapeutic Targeting of Golgi Phosphoprotein 2 (GOLPH2) with Armed Antibodies: A Preclinical Study of Anti-GOLPH2 Antibody Drug Conjugates in Lung and Colorectal Cancer Models of Patient Derived Xenografts (PDX).

Authors:  Heike Liewen; Norbert Markuly; Heinz Läubli; Yang Liu; Matthias S Matter; Nora Liewen; Christoph Renner; Alfred Zippelius; Frank Stenner
Journal:  Target Oncol       Date:  2019-10       Impact factor: 4.493

5.  GP73 is a potential marker for evaluating AIDS progression and antiretroviral therapy efficacy.

Authors:  Hongshan Wei; Xiaohua Hao; Boan Li; Xingwang Li; Jun Hou; Yong Qiao; Renwen Zhang; Xin Li
Journal:  Mol Biol Rep       Date:  2013-09-26       Impact factor: 2.316

6.  GOLM1 restricts colitis and colon tumorigenesis by ensuring Notch signaling equilibrium in intestinal homeostasis.

Authors:  Yang Pu; Ya Song; Mengdi Zhang; Caifeng Long; Jie Li; Yanan Wang; Yinzhe Xu; Fei Pan; Na Zhao; Xinyu Zhang; Yanan Xu; Jianxin Cui; Hongying Wang; Yan Li; Yong Zhao; Di Jin; Hongbing Zhang
Journal:  Signal Transduct Target Ther       Date:  2021-04-14

7.  Xenopus as a model system for the study of GOLPH2/GP73 function: Xenopus GOLPH2 is required for pronephros development.

Authors:  Leike Li; Luan Wen; Yu Gong; Guoqiang Mei; Jinsong Liu; Yonglong Chen; Tao Peng
Journal:  PLoS One       Date:  2012-06-14       Impact factor: 3.240

Review 8.  A Quest to Identify Prostate Cancer Circulating Biomarkers with a Bench-to-Bedside Potential.

Authors:  Jaspreet Singh Batra; Swati Girdhani; Lynn Hlatky
Journal:  J Biomark       Date:  2014-03-12

9.  GP73 is down-regulated in gastric cancer and associated with tumor differentiation.

Authors:  Le-Gao Chen; Hui-Ju Wang; Hai-bo Yao; Tian-Pei Guan; Fang Wu; Xu-Jun He; Ying-Yu Ma; Hou-Quan Tao; Zai-Yuan Ye
Journal:  World J Surg Oncol       Date:  2013-06-07       Impact factor: 2.754

10.  Golgi phosphoprotein 2 in physiology and in diseases.

Authors:  Ha-Jeong Kim; Dandan Lv; Yan Zhang; Tao Peng; Xiaojing Ma
Journal:  Cell Biosci       Date:  2012-09-10       Impact factor: 7.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.